NRF2 signaling in cancer cells attenuates the expression of miR-1 and miR-206 by promoting the expression of HDAC4, causing a shift in glucose metabolism to the pentose phosphate pathway (PPP) (Singh et al., 2013). This evidence concerns the gene NFE2L2 and cancer.